U.S. companies are saving some $620 billion by parking profits outside the country, according to a report Tuesday.» Read More
A major US retailer announced job cuts Monday amid worries about the fate of the stimulus plan, while a big Wall Street firm has further job cuts in store, according to reports.
A major US retailer announced job cuts Monday amid worries about the fate of the stimulus plan and the economy.
Pfizer CEO Jeffrey Kindler defends his company's plan to acquire rival Wyeth for $68 billion in the biggest pharmaceutical merger in eight years, despite a plunge of more than 16 percent in Pfizer's stock price last week.
So, what do you do at the end of a week where your company's stock was the worst performer in the Dow and you've got some bad news that could make the shares go down even more? You employ one of the oldest PR tricks in the book.
Companies are cutting jobs by the tens of thousands. State and local governments are penny-pinching, too. So what about Uncle Sam?
Following are the day's biggest winners and losers. Find out why shares of Wells Fargo and General Dynamics popped while Caterpillar and Pfizer dropped.
The guys go behind the headlines and give you their take on the dismal economics numbers that capped off the worst January ever. But there are still places where you can make fast money.
On a week dominated by earnings, the economic stimulus plan and discussions over a government-run "bad bank," the major US markets were flat to negative on the week. The Dow and S&P 500 marked their worst January on record, each dropping over 8% for the month.
Pfizer is quitting the ad agency that tried to tell smokers it's their time to quit.
Since announcing a merger with Wyeth, drugmaker Pfizer has slipped 13%. So, how should trade healthcare?
Not even big layoffs can convince investors that companies are shoring up their balance sheet and are a safe place to put money.
I need a break from blogging all-things Pfizer. Sequenom to the rescue with more data on its diagnostic test for Down Syndrome. Out of nearly 900 women there were no false negatives, but for the first time SQNM reported one false positive.
More companies announced layoffs on Thursday as the employment picture continued to dim.
Stocks rose on Wednesday, capping the S&P 500's longest winning streak since November...
The editorial board of "The Wall Street Journal" weighs in today on the Pfizer-Wyeth deal. The opinion piece details all of the well-documented problems facing big pharma and—perhaps not surprisingly coming from the WSJ editorial page—blames Washington for many of them.
Reporters could only listen to Pfizer's hastily-organized "Investor Luncheon," so I can't tell you how many people showed up or what the room looked like. But Chairman and CEO Jeff Kindler drew a pretty good picture at the start of his opening remarks.
More companies announced layoffs on Tuesday as the employment picture continued to dim.
This is the first paragraph/short story.
Investors can’t help but wonder what’s the best way to play Pharma after Pfizer said it would buy rival Wyeth for $60 billion, a 20% premium!
The Dow rose in choppy trade on Monday, with investors shrugging off a grim warning about the year ahead from Caterpillar.